See the DrugPatentWatch profile for yervoy

Yervoy Discount: Is it Available for All Doses?

Introduction

Ipilimumab, marketed under the brand name Yervoy, is a revolutionary immunotherapy medication used to treat various types of cancer, including melanoma, lung cancer, and kidney cancer. While Yervoy has shown remarkable efficacy in treating these conditions, its high cost can be a significant barrier for many patients. In this article, we will explore whether Yervoy discount is available for all doses and what options patients have to make this life-saving treatment more affordable.

What is Yervoy?

Yervoy is a monoclonal antibody that works by enhancing the body's immune response to cancer cells. It is administered intravenously and has been shown to improve overall survival rates and response rates in patients with advanced melanoma and other types of cancer. However, Yervoy is a costly medication, with a price tag of around $12,500 per dose for a 3mg injection.

Yervoy Dosage and Cost

Yervoy is typically administered at a dose of 3mg per injection, and the recommended treatment schedule is every 3 weeks for a total of 4 doses. However, some patients may require additional doses or a different dosage schedule, which can increase the overall cost of treatment. According to the manufacturer's website, the cost of Yervoy can range from $12,500 to $50,000 or more per treatment cycle, depending on the dose and treatment schedule.

Is Yervoy Discount Available for All Doses?

While Yervoy discount may be available for some patients, it is not always available for all doses. The availability of discounts and patient assistance programs (PAPs) can vary depending on the patient's insurance status, income level, and other factors. However, there are several options that patients can explore to make Yervoy more affordable.

Manufacturer's Patient Assistance Program

The manufacturer of Yervoy, Bristol-Myers Squibb (BMS), offers a patient assistance program that provides free or reduced-cost medication to eligible patients. To be eligible, patients must meet certain income and insurance requirements, and they must be receiving Yervoy for a covered indication. Patients can apply for the program through the BMS website or by contacting a BMS representative.

DrugPatentWatch.com: A Resource for Patients

According to DrugPatentWatch.com, a website that provides information on prescription medications, including pricing and patient assistance programs, Yervoy is eligible for discounts and PAPs through various programs. For example, the website notes that Yervoy is listed on the Medicare Part D formulary, which means that patients with Medicare Part D coverage may be eligible for discounts on this medication.

Other Options for Affordability

In addition to the manufacturer's patient assistance program and PAPs, patients may also be able to access Yervoy at a lower cost through other programs and services. For example:

* Patient Access Network (PAN) Foundation: This non-profit organization provides financial assistance to patients with chronic or life-threatening diseases, including cancer. Patients can apply for assistance through the PAN Foundation website.
* CancerCare: This non-profit organization provides financial assistance to patients with cancer, including help with medication costs. Patients can apply for assistance through the CancerCare website.
* Manufacturer's Co-pay Cards: Some manufacturers, including BMS, offer co-pay cards that can help patients pay for their medication. These cards can be used in conjunction with other programs and services to make Yervoy more affordable.

Conclusion

While Yervoy discount may not be available for all doses, there are several options that patients can explore to make this life-saving treatment more affordable. Patients should contact their healthcare provider or a BMS representative to learn more about the manufacturer's patient assistance program and other options for affordability.

Key Takeaways

* Yervoy is a costly medication, with a price tag of around $12,500 per dose for a 3mg injection.
* The manufacturer's patient assistance program provides free or reduced-cost medication to eligible patients.
* Patients may be able to access Yervoy at a lower cost through other programs and services, including PAPs and co-pay cards.
* Patients should contact their healthcare provider or a BMS representative to learn more about the manufacturer's patient assistance program and other options for affordability.

FAQs

1. Q: Is Yervoy discount available for all doses?
A: No, Yervoy discount may not be available for all doses. However, patients may be able to access the medication at a lower cost through other programs and services.
2. Q: How do I apply for the manufacturer's patient assistance program?
A: Patients can apply for the program through the BMS website or by contacting a BMS representative.
3. Q: What other options are available for making Yervoy more affordable?
A: Patients may be able to access Yervoy at a lower cost through PAPs, co-pay cards, and other programs and services.
4. Q: Can I use a co-pay card in conjunction with other programs and services?
A: Yes, co-pay cards can be used in conjunction with other programs and services to make Yervoy more affordable.
5. Q: How do I know if I am eligible for a patient assistance program?
A: Patients should contact their healthcare provider or a BMS representative to learn more about the manufacturer's patient assistance program and other options for affordability.

Cited Sources

1. Bristol-Myers Squibb. (2022). Yervoy (ipilimumab) Prescribing Information.
2. DrugPatentWatch.com. (2022). Yervoy (ipilimumab) Pricing and Patient Assistance Programs.
3. Patient Access Network (PAN) Foundation. (2022). Patient Assistance Programs.
4. CancerCare. (2022). Financial Assistance.
5. Manufacturer's Co-pay Cards. (2022). Co-pay Cards for Yervoy (ipilimumab).